GCNC World View: The Global Cannabis Business Podcast · GCNC

Cannabis By The Numbers: Hemp and Cannabis - A one plant solution?

·30 min·1 clip

Beau warns that restrictions on cannabinoids could have “a real devastating effect” on women’s health treatments.

1. GCNC World View: The Global Cannabis Business Podcast uses “Cannabis by the Numbers” episode four of eight to compare hemp and cannabis as a business question. 2. Host Chris is joined by Beau Whitney of Whitney Economics and Rachel Wright of Verdant Strategies, two analysts who work with market data and operator strategy. 3. The episode asks whether hemp and THC businesses should be treated as separate lanes or as parts of a “one plant” market. 4. Beau says hemp is commonly defined by the 0.3% delta-9 THC dry-weight threshold, which he calls an arbitrary line that was codified into law. 5. He argues that the line should be decoupled from the plant itself and evaluated by strain and by industrial versus non-industrial use. 6. Beau identifies a gray area for cannabinoid plants that stay under 0.3% THC but still produce intoxicating or psychotropic products. 7. He says that, on a global scale, industrial hemp applications make the intoxicating marijuana, adult-use, hemp, and medical intoxicating markets look small by comparison. 8. Beau draws a sharp distinction between the United States and “everybody else,” saying most countries normalized hemp first and layered cannabis reform afterward. 9. He says the U.S. did the reverse by deploying medical cannabis, then adult use, and now hemp, creating confusion at the international, national, state, and operator levels. 10. He proposes a policy model that puts controls at the farm-gate level and adds stricter regulation based on product intention, such as intoxicating, psychotropic, or industrial uses. 11. Beau compares the issue to orange juice production and says byproducts can have intoxicating effects even when the base crop is treated as an agricultural product. 12. Rachel says many THC operators in California and Europe are comfortable staying in their lane because they have already navigated a defined pathway. 13. She says some operators are branching into CBD wellness, smoke shops, and cross-border products, while legacy-market operators are moving into Thailand and Europe. 14. Beau says cannabinoids are increasingly being treated as ingredients, which means businesses can build around THC combinations, terpenes, and other cannabinoids. 15. Rachel extends that idea to ancillary services, saying one GCNC member focuses on multinational payments and transactions for THC businesses and does not plan to pivot into hemp. 16. Both speakers return to the idea that staying focused on core competency matters more than chasing every new sector, especially when 280E and excise-tax problems hit THC operators. 17. The tone is analytical and conversational, with Chris steering the discussion toward practical business implications and policy comparisons. 18. The format is a back-and-forth interview with examples from Germany, Texas, India, California, Europe, Thailand, and the U.S. 19. Listeners interested in cannabis policy, market sizing, and operator strategy will get the most from it. 20. Listeners wanting a product review, a consumer guide, or a fast entertainment segment may skip it.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from GCNC World View: The Global Cannabis Business Podcast